Drug Recalls — FDA Recall Database

10,690drug recall records

953FDA Class I records

8firms with 5+ records

Aidapak Services, LLC537 records

Database records

Records — page 257

10,690 detailed records are currently available in this category.

DrugOct 19, 2016

Marcaine 0.25% (bupivacaine HCl) injection, USP, 125 mg/50 mL (2.5 mg/mL), 50 mL recall — FDA D-0096-2017

Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the…

Class IIFDA: TerminatedHospira Inc., A Pfizer Company

DrugOct 19, 2016

Leiter's Compounding Moxifloxacin 1 mg/mL in Sterile Balanced Salt Solution (BSS) recall — FDA D-0016-2017

Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

Class IIFDA: TerminatedLeiter's Compounding

DrugOct 19, 2016

Pharmedium Services fentaNYL Citrate Injection, 50 mcg per mL, 250 mcg per 5 mL, 5mL Total recall — FDA D-0038-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services fentaNYL Citrate Injection, 50 mcg per mL, Preservative Free, 1 mL Total recall — FDA D-0033-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services PHENYLephrine HCl, 100 mcg per mL, 0.5 mg per 5 mL, in 0.9% Sodium recall — FDA D-0087-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services atropine Sulfate Injection, 0.4 mg per mL, 0.8 mg per 2 mL, 2 mL Total recall — FDA D-0026-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services PHENYLephrine HCl, 100 mcg per mL, 0.5 mg per 5 mL, in 0.9% Sodium recall — FDA D-0086-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Leiter's Compounding Cefuroxime Sodium 10 mg/mL in 0.9% Sodium Chloride (Injection) 1 mL recall — FDA D-0012-2017

Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

Class IIFDA: TerminatedLeiter's Compounding

DrugOct 19, 2016

Pharmedium Services ketamine HCl Injection, 50 mg per mL (100 mg per 2 mL), 2 mL Total recall — FDA D-0057-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services fentaNYL Citrate, 5 mcg per mL, 0.9% Sodium Chloride, Preservative Free recall — FDA D-0042-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services ePHEDrine Sulfate, 5 mg per mL, 25 mg per 5 mL, in 0.9% Sodium Chloride recall — FDA D-0029-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services lidocaine HCl, 2%, 20 mg per mL (60 mg per 3 mL), 3 mL Total Volume in a recall — FDA D-0069-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services HEPARIN Sodium Inj recall — FDA D-0047-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services fentaNYL Citrate, 10 mcg per mL (25 mcg per 2.5 mL), in 0.9% Sodium recall — FDA D-0041-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services HEPARIN Sodium Inj., USP, 5,000 USP Heparin Units per 5 mL Total Volume recall — FDA D-0048-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services fentaNYL Citrate, 5 mcg per mL (10 mcg per 2 mL) in 0.9% Sodium recall — FDA D-0043-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services neostigmine Methylsulfate, 1 mg per mL, 3 mg per 3 mL, 3 mL Total Volume recall — FDA D-0084-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services HEPARIN Sodium Inj recall — FDA D-0049-2017

Subpotent Drug and Stability Data Does Not Support Expiry: confirmed subpotency and potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services lidocaine HCl 2%, Preservative Free, 20 mg per mL (100 mg per 5 mL), 5 recall — FDA D-0067-2017

Stability Data Does Not Support Expiry:potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Pharmedium Services midazolam HCl, 1 mg per mL (3 mg per 3 mL), in 0.9% Sodium Chloride, 3 recall — FDA D-0074-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Allergan Sales TAZORAC (tazarotene) Gel 0.05% recall — FDA D-0099-2017

Failed Content Uniformity Specifications

Class IIFDA: TerminatedAllergan Sales, LLC

DrugOct 19, 2016

Pharmedium Services neostigmine Methylsulfate, 1 mg per mL, 5 mg per 5 mL, 5 mL Total Volume recall — FDA D-0082-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

DrugOct 19, 2016

Leiter's Compounding Vancomycin 10 mg/mL in 0.9% Sodium Chloride (Injection) 1 mL Total recall — FDA D-0018-2017

Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

Class IIFDA: TerminatedLeiter's Compounding

DrugOct 19, 2016

Pharmedium Services ePHEDrine Sulfate, 10 mg per mL, 50 mg per 5 mL, in 0.9% Sodium recall — FDA D-0030-2017

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Class IIFDA: TerminatedPharmedium Services, LLC

How to use this drug recall index

A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.

Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.

What the database can and cannot tell you

This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.

Drug Recalls in the United States

Records — page 257

How to use this drug recall index

What the database can and cannot tell you